The Two Sides of YY1 in Cancer: A Friend and a Foe

Frontiers in Oncology- Switzerland

doi 10.3389/fonc.2019.01230

Full Text

Abstract

Available in

Date

Authors

Publisher

Frontiers Media SA

Related search

Molecular Pathways: Is AMPK a Friend or a Foe in Cancer?

Clinical Cancer Research
Cancer ResearchOncology
2015English

Pancreatic Cancer Stroma: Friend or Foe?

Cancer Cell
Cancer ResearchOncologyCell Biology
2014English

Breast Cancer Cell Lines: Friend or Foe?

Breast Cancer Research
Cancer ResearchOncology
2003English

Lithium in the Kidney: Friend and Foe?

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2015English

Friend or Foe?

Archives of Internal Medicine
2000English

Endoplasmic Reticulum Quality Control in Cancer: Friend or Foe

Seminars in Cancer Biology
Cancer Research
2015English

Athlete's Heart Syndrome: A Friend or Foe?

Medicinski podmladak
2016English

Ectoplasmic Specialization: A Friend or a Foe of Spermatogenesis?

BioEssays
BiochemistryGeneticsMolecular Biology
2006English

Azathioprine: Friend or Foe?

British Journal of Dermatology
DermatologyMedicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy